Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.28 - $1.16 $3,500 - $14,499
12,500 Added 39.68%
44,000 $14,000
Q1 2024

May 15, 2024

BUY
$1.06 - $1.67 $33,390 - $52,605
31,500 New
31,500 $36.5 Million
Q4 2023

Aug 14, 2024

SELL
$1.26 - $1.79 $8,190 - $11,635
-6,500 Reduced 16.25%
33,500 $56.6 Million
Q3 2023

Aug 14, 2024

BUY
$1.61 - $2.54 $33,810 - $53,340
21,000 Added 110.53%
40,000 $72.4 Million
Q1 2023

Aug 14, 2024

BUY
$1.2 - $2.19 $7,200 - $13,140
6,000 Added 46.15%
19,000 $25.3 Million
Q3 2022

Aug 14, 2024

BUY
$0.73 - $3.74 $7,665 - $39,270
10,500 Added 420.0%
13,000 $40.6 Million
Q1 2022

Aug 14, 2024

SELL
$2.83 - $8.69 $117,445 - $360,635
-41,500 Reduced 94.32%
2,500 $10.1 Million
Q4 2021

Aug 30, 2024

SELL
$8.31 - $14.92 $357,330 - $641,560
-43,000 Reduced 97.73%
1,000 $8.31 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.